San Diego-based connected sleep device maker ResMed and Alphabet's life science offshoot Verily announced the formation of Primasun, an end-to-end solution to help employers and healthcare providers identify populations at risk for complex sleep disorders.
Formed as a joint venture, Primasun will initially evaluate patients with insomnia, provide guidance to improve sleep hygiene and connect...
San Diego-based medical device company ResMed has announced the acquisition of mementor, a consumer software developer that offers a digital solution for insomnia.
The financial terms of the transaction were not disclosed.
The acquisition of Leipzig, Germany-based mementor lays the foundation for ResMed to build its digital sleep medicine portfolio in Germany, the company said. The deal was...
Connected respiratory device maker ResMed signed a definitive agreement to acquire Medifox Dan, a German out-of-hospital software company, from software investor Hg for $1 billion (€950 million).
Medifox Dan provides tools for staffing plans, billing, care documentation and administration for nursing homes, home health agencies and outpatient therapy providers. The acquisition is expected to...
Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea.
The new machine has many of the same specs as ResMed’s previous device, the AirSense 10, but also includes exclusive access to new features. These include device set-up tutorials on the myAir patient engagement app,...
The Consumer Technology Association and the Connected Health Initiative announced this morning a new multi-sector initiative of private tech companies, healthcare providers and representatives of public agencies that aims to outline technology's role in addressing health disparities exacerbated by COVID-19.
To this end, the effort's first major project will consist of a white paper containing...
Novartis and respiratory health company Propeller Health, a ResMed subsidiary, have teamed up to co-package the latter’s digital health platform with the pharma giant’s new asthma medication Enerzair Breezhaler.
This news come shortly after the product landed European Commission clearance. The co-packaged product will be launching in the EU during 2020. However, it is not yet available in the U....
Over the last few months respiratory health has become a major area of focus within the medical community and beyond, as COVID-19 on takes its toll. However, respiratory conditions have long impacted the American public. In fact, the CDC reports that 19.2 million US adults have asthma.
As in many areas of health, today we are seeing the rise of digital for monitoring and treating respiratory...
More than half of Americans are using at least one digital data collection tool to monitor their health, according to a new survey released by ResMed, maker of connected respiratory devices.
The report, which came out last Friday, was based on the survey results of 3,001 participants based in the U.S. In June, responders over the age of 18 years took the 15-minute survey. The results comprised...
Respiratory health company Propeller Health, which was recently acquired by ResMed for $225 million, announced this week in San Francisco a partnership with Walgreens and a new feature for users of its platform.
The new feature, called My Pharmacy, will allow Propeller’s end users, patients with asthma and COPD, to connect to pharmacy services without leaving the Propeller app. At launch, users...
This morning ResMed, maker of connected respiratory devices, announced that it is acquiring Wisconsin-based digital respiratory health company Propeller Health for $225 million.
ResMed, a publicly traded company, is set to finalize the acquisition of Propeller Health by March 2019, which marks the end of its 2019 fiscal year.
Propeller is best known for its smart inhalers that help people...
